Akira Hiramatsu

Hiroshima, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 137 publications

Atezolizumab plus Bevacizumab with Transcatheter Arterial Chemoembolization (Sandwich Strategy) versus Atezolizumab plus Bevacizumab Alone in Hepatocellular Carcinoma: A Multicenter Retrospective Study.

Atezolizumab plus Bevacizumab with Transcatheter Arterial Chemoembolization (Sandwich Strategy) versus Atezolizumab plus Bevacizumab Alone in Hepatocellular Carcinoma: A Multicenter Retrospective Study.

Journal: Liver cancer
Published: February 19, 2025

Advanced liver fibrosis is associated with decreased gait speed in older patients with chronic liver disease.

Advanced liver fibrosis is associated with decreased gait speed in older patients with chronic liver disease.

Journal: Scientific reports
Published: December 10, 2023

Outcomes of Patients with Child-Pugh B and Unresectable Hepatocellular Carcinoma Undergoing First-Line Systemic Treatment with Sorafenib, Lenvatinib, or Atezolizumab Plus Bevacizumab.

Outcomes of Patients with Child-Pugh B and Unresectable Hepatocellular Carcinoma Undergoing First-Line Systemic Treatment with Sorafenib, Lenvatinib, or Atezolizumab Plus Bevacizumab.

Journal: Oncology
Published: April 12, 2023

Impact of fibrosis on liver-related event incidence in nonalcoholic fatty liver disease: A multicenter observational study.

Impact of fibrosis on liver-related event incidence in nonalcoholic fatty liver disease: A multicenter observational study.

Journal: Hepatology research : the official journal of the Japan Society of Hepatology
Published: March 12, 2023

Analysis of Lenvatinib's Efficacy against Intermediate-Stage Unresectable Hepatocellular Carcinoma.

Analysis of Lenvatinib's Efficacy against Intermediate-Stage Unresectable Hepatocellular Carcinoma.

Journal: Cancers
Published: August 02, 2022

Clinical features of patients with chronic liver disease in Japan related to alcohol use: Nationwide examination using alcohol use disorders identification test.

Clinical features of patients with chronic liver disease in Japan related to alcohol use: Nationwide examination using alcohol use disorders identification test.

Journal: Hepatology research : the official journal of the Japan Society of Hepatology
Published: July 22, 2022

Impact of skeletal muscle volume on patients with BCLC stage-B hepatocellular carcinoma undergoing sorafenib therapy.

Impact of skeletal muscle volume on patients with BCLC stage-B hepatocellular carcinoma undergoing sorafenib therapy.

Journal: Cancer medicine
Published: July 16, 2022

Analysis of Survival and Response to Lenvatinib in Unresectable Hepatocellular Carcinoma.

Analysis of Survival and Response to Lenvatinib in Unresectable Hepatocellular Carcinoma.

Journal: Cancers
Published: December 12, 2021

Underestimation of impaired glucose tolerance and usefulness of a continuous glucose monitoring system in chronic liver disease.

Underestimation of impaired glucose tolerance and usefulness of a continuous glucose monitoring system in chronic liver disease.

Journal: Journal of gastroenterology and hepatology
Published: November 18, 2021

Management of Systemic Therapies and Hepatic Arterial Infusion Chemotherapy in Patients with Advanced Hepatocellular Carcinoma Based on Sarcopenia Assessment.

Management of Systemic Therapies and Hepatic Arterial Infusion Chemotherapy in Patients with Advanced Hepatocellular Carcinoma Based on Sarcopenia Assessment.

Journal: Liver cancer
Published: October 11, 2021

Proposal for new sleep disorder criteria in patients with chronic liver disease: Influence of liver-related complications.

Proposal for new sleep disorder criteria in patients with chronic liver disease: Influence of liver-related complications.

Journal: Hepatology research : the official journal of the Japan Society of Hepatology
Published: August 31, 2021

Complete Response for Advanced Hepatocellular Carcinoma by Conversion Surgery Therapy Following a Good Response of Regorafenib Despite Rapid Progressive Disease with Sorafenib.

Complete Response for Advanced Hepatocellular Carcinoma by Conversion Surgery Therapy Following a Good Response of Regorafenib Despite Rapid Progressive Disease with Sorafenib.

Journal: Internal medicine (Tokyo, Japan)
Published: July 01, 2021
Showing 1-12 of 137

Last Updated: 09/26/2026